title: Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation.
authors.forename: Adriana
authors.initials: A
authors.lastname: Balduzzi
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Rossi
authors.forename: Lilia
authors.initials: L
authors.lastname: Corral
authors.forename: Sonia
authors.initials: S
authors.lastname: Bonanomi
authors.forename: Daniela
authors.initials: D
authors.lastname: Longoni
authors.forename: Attilio
authors.initials: A
authors.lastname: Rovelli
authors.forename: Valentino
authors.initials: V
authors.lastname: Conter
authors.forename: Andrea
authors.initials: A
authors.lastname: Biondi
authors.forename: Cornelio
authors.initials: C
authors.lastname: Uderzo
mesh_terms: D015703:Antigens, CD / Q000097:blood; D015214:Antigens, Differentiation, Myelomonocytic / Q000097:blood; D002880:Chromosomes, Human, Pair 11; D002894:Chromosomes, Human, Pair 4; D006650:Histocompatibility Testing; D006801:Humans; D017710:Lymphocyte Transfusion; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D012008:Recurrence; D063268:Sialic Acid Binding Ig-like Lectin 3; D033581:Stem Cell Transplantation; D014178:Translocation, Genetic
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; D063268:Sialic Acid Binding Ig-like Lectin 3